Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$3.23 - $6.83 $17,765 - $37,565
-5,500 Reduced 13.83%
34,276 $0
Q3 2022

Oct 31, 2022

SELL
$4.95 - $11.08 $22,275 - $49,860
-4,500 Reduced 10.16%
39,776 $197,000
Q1 2022

Apr 27, 2022

BUY
$8.58 - $15.03 $8,580 - $15,030
1,000 Added 2.31%
44,276 $387,000
Q4 2021

Jan 31, 2022

SELL
$11.52 - $15.36 $184,320 - $245,760
-16,000 Reduced 26.99%
43,276 $636,000
Q3 2021

Nov 03, 2021

SELL
$13.63 - $18.81 $6,815 - $9,405
-500 Reduced 0.84%
59,276 $842,000
Q2 2021

Jul 30, 2021

SELL
$15.87 - $22.53 $150,765 - $214,035
-9,500 Reduced 13.71%
59,776 $974,000
Q1 2021

Apr 29, 2021

SELL
$15.8 - $28.15 $18,960 - $33,780
-1,200 Reduced 1.7%
69,276 $1.42 Million
Q4 2020

Jan 28, 2021

SELL
$9.14 - $20.08 $45,700 - $100,399
-5,000 Reduced 6.62%
70,476 $1.12 Million
Q3 2019

Oct 28, 2019

BUY
$5.18 - $9.68 $146,076 - $272,976
28,200 Added 59.65%
75,476 $525,000
Q2 2019

Jul 30, 2019

BUY
$6.3 - $12.4 $297,838 - $586,222
47,276 New
47,276 $379,000

Others Institutions Holding RAD

About RITE AID CORP


  • Ticker RAD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 56,535,400
  • Market Cap $9.61M
  • Description
  • Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter m...
More about RAD
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.